Back to search results
NCT07307664

Increasing Germline Genetic Testing for Patients With Cancer

Recruiting
NAAll AgesInterventional
Josh Peterson
~1,000 participants
Updated 2026-06-09 on ClinicalTrials.gov
What's tested:Implementation strategies

At a glance

Recruiting sites
10 of 10 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Germline Genetic Testing Ordered for Breast Cancer Patients
Measured over 48 months
+2 more outcomes measured

Conditions

Hereditary Pancreatic Cancer
Conditions or Focus of Study
Hereditary Breast Cancer
Hereditary Colorectal Cancer

Explore related trials

Breast CarcinomaColorectal CarcinomaPancreatic Carcinoma

Where it's being run

10 sites across 9 states
North Carolina2
California1
Florida1
Georgia1
Illinois1
Indiana1
Pennsylvania1
Tennessee1

Study leadership

  • Josh F Peterson, MD, MPH · PRINCIPAL_INVESTIGATOR · Vanderbilt University Medical Center

Who to contact

Megan He, PhD
[email protected]
615-875-9641
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Oncology care team members (including, but not limited to, oncologists, advanced practice providers, nurse navigators, caring for patients with adult patients with breast cancer, pancreatic cancer or colorectal cancer.

Exclusion

Providers not on the oncology care team

What this trial measures

  • Germline Genetic Testing Ordered for Breast Cancer Patients48 months

    Number of eligible breast cancer patients with germline genetic testing ordered by an oncology care team provider, or associated with an oncology visit, within 7 days of an oncology encounter divided by the number of eligible breast cancer patients seen by the oncology team

  • Germline Genetic Testing Ordered for Pancreatic Cancer Patients48 months

    Number of eligible pancreatic cancer patients with germline genetic testing ordered by an oncology care team provider, or associated with an oncology visit, within 7 days of an oncology encounter divided by the number of eligible pancreatic cancer patients seen by the oncology care team.

  • Germline Genetic Testing Ordered for Colorectal Cancer Patients48 months

    Number of eligible colorectal cancer patients with germline genetic testing ordered by an oncology care team provider, or associated with an oncology visit, within 7 days of an oncology encounter divided by the number of eligible colorectal cancer patients seen by the oncology care team.